|
|
|
|
| LEADER |
02724nam a2200253 a 4500 |
| 001 |
1019000 |
| 005 |
20171111232336.0 |
| 008 |
070427s2007 gr erb 001 0 eng d |
| 020 |
|
|
|a 9780471752158
|q (cloth)
|
| 020 |
|
|
|a 0471752150
|q (cloth)
|
| 040 |
|
|
|a GrAtEKP.sci
|b gre
|e AACR2
|
| 082 |
|
0 |
|2 22
|a 615.19
|
| 245 |
0 |
4 |
|a The art of drug synthesis/
|c edited by Douglas S. Johnson, Jie Jack Li
|
| 260 |
|
|
|a Hoboken, N.J.:
|b Wiley-Interscience,
|c c2007
|
| 300 |
|
|
|a xv, 276 p. :
|b ill., plat. ;
|c 26 cm.
|
| 504 |
|
|
|a Includes bibliographical references and index
|
| 505 |
1 |
|
|a The role of medicinal chemistry in drug discovery / John A. Lowe III -- Process research: how much? how soon? / Neal G. Anderson -- Aromatase inhibitors for breast cancer : exemestane (Aromasin), anastrozole (Arimidex), and letrozole (Femara) / Jie Jack Li -- Quinolone antibiotics : levofloxacin (Levaquin), moxifloxacin (Avelox), gemifloxacin (Factive), and garenoxacin (T-3811) / Chris Limberakis -- Triazole antifungals : itraconazole (Sporanox), fluconazole (Diflucan), voriconazole (Vfend), and fosfluconazole (Prodif) / Andrew S. Bell -- Non-nucleoside HIV reverse transcriptase inhibitors / Arthur Harms -- Neuraminidase inhibitors for influenza : oseltamivir phosphate (Tamiflu) and zanamivir (Relenza) / Douglas S. Johnson and Jie Jack Li -- Peroxisome proliferator-activated receptor (PPAR) agonists for type 2 diabetes / Jin Li -- Angiotensin AT1 antagonists for hypertension / Larry Yet -- Leading ACE inhibitors for hypertension / Victor J. Cee and Edward J. Olhava -- Dihydropyridine calcium channel blockers for hypertension / Daniel P. Christen -- Second-generation HMG-CoA reductase inhibitors / Jeffrey A. Pfefferkorn -- Cholesterol absorption inhibitors: ezetimibe (zetia) / Stuart B. Rosenblum -- Dual selective serotonin and norepinephrine reuptake inhibitors (SSNRIs) for depression / Marta Pi?iro-N?nez -- GABA receptor agonists for insomnia : zolpidem (Ambien), zaleplon (Sonata), eszopiclone (Estorra, Lunesta), and indiplon / Peter R. Guzzo -- Ligands: neurontin (Gabapentin) and lyrica (Pregabalin) / Po-Wai Yuen -- Approved treatments for attention deficit hyperactivity disorder : amphetamine (Adderall), methylphenidate (Ritalin), and atomoxetine (Straterra) / David L. Gray
|
| 650 |
1 |
0 |
|a Drugs
|x Design
|
| 650 |
|
0 |
|a Pharmaceutical chemistry
|
| 650 |
|
2 |
|a Pharmaceutical chemistry
|
| 700 |
1 |
|
|a Johnson, Douglas S.
|
| 856 |
4 |
0 |
|a Li, Jie Jack
|u http://www.loc.gov/catdir/toc/ecip0717/2007017891.html
|u http://www.loc.gov/catdir/enhancements/fy0739/2007017891-b.html
|
| 856 |
4 |
0 |
|u http://www.loc.gov/catdir/enhancements/fy0739/2007017891-d.html
|
| 952 |
|
|
|a GrAtEKP
|b 59ccd6fc6c5ad1344609e959
|c 998a
|d 945l
|e 615.19 JonD a 2007
|t 2
|x m
|z Books
|
